Register Now - Unlocking Longitudinal Patient-Reported Outcomes: The Untapped Value of Specialty Pharmacyocking
|Articles|September 30, 2009

DecisionView's StudyOptimizer Now Available as Software-as-a-Service

DecisionView (San Francisco, CA) announced today that its Web-based enrollment application, StudyOptimizer, will now be available as Software-as-a-Service (SAS). In addition to faster deployment, the pay-as-you-go version will deliver a lower cost of ownership, says the company.

"We realized the importance of accelerating the adoption of our solution, so that customers could implement corrective actions in their enrollment processes as quickly as possible," said Jim Scullion, Chief Executive Officer of DecisionView. "With the launch of this new offering, companies can leverage the planning and forecasting capabilities of StudyOptimizer in a shorter time frame, even on a single trial."

The SAS model will be hosted in a SAS70 certified infrastructure and is available now.


Related to this article

Where AI Leads in Trial Design—and Where Humans Still Need To
In this video interview, Claire Riches, VP of clinical solutions at Citeline, makes the case for AI as a sophisticated strategic advisor in trial design while arguing that humans must remain in the lead—especially when factors the model can't fully account for are at stake.